Skip to main content
Clinical Trials/NCT04631796
NCT04631796
Completed
Not Applicable

Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens

Alcon Research1 site in 1 country36 target enrollmentDecember 3, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Refractive Errors
Sponsor
Alcon Research
Enrollment
36
Locations
1
Primary Endpoint
Front Surface Wettability, by Category
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The primary objective of this study is to evaluate the overall clinical performance of an investigational silicone hydrogel contact lens over 2 weeks of daily wear.

Detailed Description

Participants will attend a Screening visit, a Dispense visit (0 to 4 days later), and a follow-up visit approximately 2 weeks after the Dispense visit.

Registry
clinicaltrials.gov
Start Date
December 3, 2020
End Date
December 31, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Understand and sign an Informed Consent that has been approved by an Institutional Review Board.
  • Successful wear of spherical weekly/monthly soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months.
  • Willing to stop wearing habitual contact lenses for the duration of study participation.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • Any condition that contraindicates contact lens wear, as determined by the Investigator.
  • Any use of systemic or ocular medications that contraindicates contact lens wear, as determined by the Investigator.
  • History of refractive surgery or plan to have refractive surgery during the study.
  • Current or history of dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear.
  • Habitual contact lenses worn in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
  • Any use of topical ocular medications or artificial tear or rewetting drops that would require instillation during contact lens wear.
  • Monovision or multifocal contact lens wear.
  • Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

Front Surface Wettability, by Category

Time Frame: Dispense; Week 2 Follow-up

Front surface wettability (i.e., assessment of the disruption of the front surface wettability of the contact lens) was assessed by the investigator for each eye individually. Front surface wettability was collected on a 5-point scale, where where Grade 0 = a smooth uniformly reflecting surface and Grade 4 = non-wettable lens surface. No formal hypothesis was predefined for the primary endpoint. No inferential testing was performed.

Study Sites (1)

Loading locations...

Similar Trials